Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management | Medscape

A Game Changer 🚨 The recent approval of Zongertinib marks the first oral TKI for HER2-mutated NSCLC. This introduces a significant new option alongside established antibody-drug conjugates. Our experts discuss the impact of this turning point ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Highlighting the Evolution of Care in Prostate Cancer - Coverage From the 2025 Global Oncology Meeting In this exclusive live event, 3 internationally recognized experts -- Dr Neal Shore, Dr Tanya Dorff, and Dr Alicia Morgans – illuminate key advances in prostate cancer treatment unveiled at this year's premier global oncology meeting. Topics of discussion will include the latest data on treatments for advanced prostate cancer, including second-generation antiandrogen therapies, AKT inhibitors,

Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape

2.3K views · 24 reactions | Medscape: For all your breaking medical news, in-depth commentary and free Continuing Education activities (CME/CE). Word up. | Medscape | Facebook